Mastocytosis complicating pregnancy.
OBJECTIVE
To review the experience of women who conceived after developing mastocytosis and who were observed at the National Institutes of Health.


METHODS
We reviewed our patient database for the years 1984-1998 to identify women with mastocytosis who had conceived. We then reviewed each woman's record, asked each woman to complete a questionnaire, and with permission wrote outside hospitals to obtain records of each labor and delivery.


RESULTS
We identified eight women who had become pregnant. These women delivered a total of 11 live infants. In approximately a third of the pregnancies, patients experienced worsening of symptoms. They often used fewer medications during pregnancy because of safety concerns, and no greater incidence of adverse reactions was noted. Antihistamines were used most commonly, followed by oral prednisone. Medications used during delivery were well tolerated and included epidural analgesics. Neonates were generally healthy. None to date have developed urticaria pigmentosa or systemic mastocytosis.


CONCLUSIONS
A subset of women with mastocytosis might have had exacerbated mastocytosis during and after pregnancy, but labor and delivery progressed normally. Infants were born generally healthy and were without mastocytosis. Thus there appears to be no absolute contraindication to pregnancy for women with mastocytosis, although women should be aware that the choice to have a child is not without some added risk.
Worobec
A S
AS
Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1881, USA. aworobec@niaid.nih.gov
Akin
C
C
Scott
L M
LM
Metcalfe
D D
DD
D000328:Adult; D016362:Analgesia, Obstetrical; D005260:Female; D006801:Humans; D008415:Mastocytosis / Q000150:complications; D011247:Pregnancy; D011248:Pregnancy Complications; D011256:Pregnancy Outcome; D011537:Pruritus / Q000209:etiology; D012189:Retrospective Studies